White label ELPA - ClinicalTrials.eu

Study on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function

Not recruiting

3 1 1
Investigated Diseases:
- IgA nephropathy
Investigated Drugs:
- Ravulizumab
+6
Study on NVD-003 Bone Graft for Treating Congenital Pseudarthrosis of the Tibia in Children

Not recruiting

1 1 1
Investigated Diseases:
- Congenital pseudarthrosis
Investigated Drugs:
- Autologous Adipose-Derived Stem Cells
Study of Batoclimab for Treating Patients with Active Thyroid Eye Disease

Not recruiting

3 1
Investigated Diseases:
- Endocrine ophthalmopathy
Investigated Drugs:
- Batoclimab
Study on the Effectiveness and Tolerability of Oral vs. Subcutaneous Methotrexate for Patients with Early Rheumatoid Arthritis

Not recruiting

3 1 1 1
Investigated Diseases:
- Rheumatoid arthritis
Investigated Drugs:
- Methotrexate
Study of Capivasertib and Paclitaxel for Patients with Advanced or Metastatic Triple-Negative Breast Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Triple negative breast cancer
Investigated Drugs:
- Capivasertib
- Paclitaxel
Study Comparing Regorafenib and Regorafenib-Irinotecan Combination for Patients with Metastatic Colorectal Cancer After Standard Treatments Have Failed

Not recruiting

3 1 1 1
Investigated Diseases:
- Colorectal cancer metastatic
Investigated Drugs:
- Irinotecan
- Regorafenib
Study Comparing Risankizumab and Deucravacitinib for Adults with Moderate Plaque Psoriasis Eligible for Systemic Therapy

Not recruiting

3 1 1 1
Investigated Diseases:
- Psoriasis
Investigated Drugs:
- Deucravacitinib
- Risankizumab
+1
Study on Osimertinib and Chemotherapy for Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
- Non-small cell lung cancer metastatic
Investigated Drugs:
Study on the Safety and Tolerability of Teprotumumab for Patients with Thyroid Eye Disease

Not recruiting

3 1
Investigated Diseases:
- Endocrine ophthalmopathy
Investigated Drugs:
- Teprotumumab
Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Not recruiting

3 1 1
Investigated Diseases:
- Relapsing multiple sclerosis
Investigated Drugs:
+9

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies